Search

everythinglearnresearchcommunity

for

Search:↓

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Compound 7p shows strong potential as an anticancer agent.

Cetuximab can cause unusual hair growth and hair loss.

A new compound shows promise as a topical treatment for hair loss.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Erlotinib may cause scarring hair loss.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Sorafenib can cause a unique skin reaction.

Janus kinase inhibitors may help treat lichen planopilaris.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

A new genetic mutation causing Xeroderma Pigmentosum was found in an 8-year-old girl, affecting her DNA repair.